Welcome to LookChem.com Sign In|Join Free

CAS

  • or

70456-63-2

Post Buying Request

70456-63-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

70456-63-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 70456-63-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,4,5 and 6 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 70456-63:
(7*7)+(6*0)+(5*4)+(4*5)+(3*6)+(2*6)+(1*3)=122
122 % 10 = 2
So 70456-63-2 is a valid CAS Registry Number.

70456-63-2Relevant articles and documents

Electrophile-Directed Diastereoselective Oxonitrile Alkylations

Chepyshev, Sergiy V.,Pitta, Bhaskar Reddy,Vangala, Saidi Reddy,Lujan-Montelongo, J. Armando,Steward, Omar W.,Fleming, Fraser F.

, p. 2850 - 2853 (2018)

Diastereoselective alkylation of prochiral oxonitrile dianions with secondary alkyl halides efficiently installs two contiguous stereogenic centers. The confluence of nucleophilic trajectory and the electrophile chirality causes distinct steric differences that allow efficient discrimination for one of the six possible conformers. Numerous oxonitrile-derived dianions efficiently displace secondary alkyl halides propagating the electrophile chirality to efficiently install two contiguous tertiary centers. The prevalence of chiral, secondary electrophiles makes the interdigitated alkylation of chiral electrophiles a particularly attractive route because the resulting oxonitriles are readily transformed into bioactive heterocycles.

Substituted 3-cyanopyridines as protein kinase inhibitors

-

Page/Page column 28, (2008/06/13)

The present teachings provide compounds of formula I and their pharmaceutically acceptable salts, hydrates, and esters, wherein R1, R2, and X are as defined herein. The present teachings also provide methods of making the compounds of formula I, and methods of treating autoimmune and inflammatory diseases by administering a therapeutically effective amount of a compound or compounds of formula I to a mammal including a human.

Synthesis of the isoquino[1,2-c][1,4]benzothiazine ring system

Kukla

, p. 2934 - 2936 (2007/10/10)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 70456-63-2